| 1 | Waardenburg syndrome | Enrichment | MITF, PAX3, SOX10 | 6.29 |
| 2 | Waardenburg syndrome, type 1 | Enrichment | MITF, PAX3, SOX10 | 6.05 |
| 3 | Waardenburg syndrome, type 2e | Enrichment | KITLG, MITF, SOX10 | 6.05 |
| 4 | Waardenburg syndrome, type 2a | Enrichment | MITF, SOX10 | 4.57 |
| 5 | Testicular germ cell tumor | Enrichment | KIT, KITLG | 3.88 |
| 6 | Waardenburg syndrome, type 4a | Enrichment | MITF, SOX10 | 3.88 |
| 7 | Ellis-van creveld syndrome | Enrichment | PRKACA, PRKACB | 3.50 |
| 8 | Melanoma | Enrichment | MC1R, MITF | 3.40 |
| 9 | Specific learning disability | Enrichment | MAPK1, RPS6KA3 | 3.32 |
| 10 | Melanoma, cutaneous malignant 1 | Enrichment | MC1R, MITF | 2.93 |
| 11 | Rare genetic deafness | Enrichment | MITF, PAX3, SOX10 | 2.76 |
| 12 | Craniofacial-deafness-hand syndrome | Enrichment | PAX3 | 2.52 |
| 13 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 2.52 |
| 14 | Waardenburg syndrome, type 3 | Enrichment | PAX3 | 2.52 |
| 15 | Coffin-lowry syndrome | Enrichment | RPS6KA3 | 2.52 |
| 16 | Mastocytosis, cutaneous | Enrichment | KIT | 2.52 |
| 17 | Carney complex, type 1 | Enrichment | PRKAR1A | 2.52 |
| 18 | Heterochromia iridis | Enrichment | MITF | 2.52 |
| 19 | Hyperpigmentation with or without hypopigmentation, familial progressive | Enrichment | KITLG | 2.52 |
| 20 | Tietz albinism-deafness syndrome | Enrichment | MITF | 2.52 |
| 21 | Increased analgesia from kappa-opioid receptor agonist, female-specific | Enrichment | MC1R | 2.52 |
| 22 | Deafness, autosomal recessive 44 | Enrichment | ADCY1 | 2.52 |
| 23 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.52 |
| 24 | Skin/hair/eye pigmentation, variation in, 2 | Enrichment | MC1R | 2.52 |
| 25 | Intellectual developmental disorder, x-linked 19 | Enrichment | RPS6KA3 | 2.52 |
| 26 | Cardioacrofacial dysplasia 2 | Enrichment | PRKACB | 2.52 |
| 27 | Myxoma, intracardiac | Enrichment | PRKAR1A | 2.52 |
| 28 | Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness | Enrichment | MITF | 2.52 |
| 29 | Skin/hair/eye pigmentation, variation in, 7 | Enrichment | KITLG | 2.52 |
| 30 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 2.52 |
| 31 | Melanoma, cutaneous malignant 5 | Enrichment | MC1R | 2.52 |
| 32 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 2.52 |
| 33 | Chronic mast cell leukemia | Enrichment | KIT | 2.52 |
| 34 | Deafness, autosomal dominant 69 | Enrichment | KITLG | 2.52 |
| 35 | Symptomatic form of coffin-lowry syndrome in female carriers | Enrichment | RPS6KA3 | 2.52 |
| 36 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 2.52 |
| 37 | Isolated bone marrow mastocytosis | Enrichment | KIT | 2.52 |
| 38 | Smoldering systemic mastocytosis | Enrichment | KIT | 2.52 |
| 39 | Mastocytosis | Enrichment | KIT | 2.52 |
| 40 | Familial progressive hyperpigmentation | Enrichment | KITLG | 2.52 |
| 41 | Cutaneous mastocytoma | Enrichment | KIT | 2.52 |
| 42 | Typical urticaria pigmentosa | Enrichment | KIT | 2.52 |
| 43 | Nodular urticaria pigmentosa | Enrichment | KIT | 2.52 |
| 44 | Pseudoxanthomatous diffuse cutaneous mastocytosis | Enrichment | KIT | 2.52 |
| 45 | Telangiectasia macularis eruptiva perstans | Enrichment | KIT | 2.52 |
| 46 | Acute mast cell leukemia | Enrichment | KIT | 2.52 |
| 47 | Familial progressive hyper- and hypopigmentation | Enrichment | KITLG | 2.52 |
| 48 | Plaque-form urticaria pigmentosa | Enrichment | KIT | 2.52 |
| 49 | Bullous diffuse cutaneous mastocytosis | Enrichment | KIT | 2.52 |
| 50 | Testis seminoma | Enrichment | KIT | 2.52 |
| 51 | Scoliosis, isolated 1 | Enrichment | MAPK7 | 2.22 |
| 52 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 2.22 |
| 53 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 2.22 |
| 54 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | PRKAR1A | 2.22 |
| 55 | Waardenburg syndrome, type 4c | Enrichment | SOX10 | 2.22 |
| 56 | Piebald trait | Enrichment | KIT | 2.22 |
| 57 | Bleeding disorder, platelet-type, 19 | Enrichment | PRKACG | 2.22 |
| 58 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 2.22 |
| 59 | Waardenburg syndrome, type 2f | Enrichment | KITLG | 2.22 |
| 60 | Menke-hennekam syndrome 2 | Enrichment | EP300 | 2.22 |
| 61 | Usher syndrome, type iv | Enrichment | PRKAR1A | 2.22 |
| 62 | Intravascular large b-cell lymphoma | Enrichment | BCL2 | 2.22 |
| 63 | Melanoma, cutaneous malignant 8 | Enrichment | MITF | 2.22 |
| 64 | Acrodysostosis | Enrichment | PRKAR1A | 2.22 |
| 65 | Papillary renal cell carcinoma | Enrichment | MITF | 2.22 |
| 66 | Body mass index quantitative trait locus 19 | Enrichment | ADCY3 | 2.22 |
| 67 | Fibrolamellar carcinoma | Enrichment | PRKACA | 2.22 |
| 68 | Peripheral demyelinating neuropathy, central dysmyelination, waardenburg syndrome, and hirschsprung disease | Enrichment | SOX10 | 2.22 |
| 69 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 2.22 |
| 70 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 2.22 |
| 71 | B-lymphoblastic leukemia/lymphoma with t | Enrichment | KIT | 2.22 |
| 72 | Inherited cancer-predisposing syndrome | Enrichment | KIT, MITF, PRKAR1A | 2.13 |
| 73 | Obesity, early-onset, with adrenal insufficiency and red hair | Enrichment | POMC | 2.04 |
| 74 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL2 | 2.04 |
| 75 | Testicular germ cell cancer | Enrichment | KIT | 2.04 |
| 76 | Melanoma of soft tissue | Enrichment | CREB1 | 2.04 |
| 77 | Obesity due to pro-opiomelanocortin deficiency | Enrichment | POMC | 2.04 |
| 78 | Body mass index quantitative trait locus 11 | Enrichment | ADCY3, POMC | 2.00 |
| 79 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | KITLG, MITF | 1.97 |
| 80 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.92 |
| 81 | Carney complex variant | Enrichment | PRKAR1A | 1.92 |
| 82 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.92 |
| 83 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | KIT | 1.92 |
| 84 | Systemic mastocytosis with associated hematologic neoplasm | Enrichment | KIT | 1.92 |
| 85 | Clear cell papillary renal cell carcinoma | Enrichment | MITF | 1.92 |
| 86 | Albinism, oculocutaneous, type ii | Enrichment | MC1R | 1.82 |
| 87 | Hypogonadotropic hypogonadism 1 with or without anosmia | Enrichment | SOX10 | 1.82 |
| 88 | Rhabdomyosarcoma 2 | Enrichment | PAX3 | 1.82 |
| 89 | Rubinstein-taybi syndrome 2 | Enrichment | EP300 | 1.82 |
| 90 | Follicular lymphoma | Enrichment | BCL2 | 1.82 |
| 91 | Acute myeloid leukemia with maturation | Enrichment | KIT | 1.82 |
| 92 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | Enrichment | KIT | 1.82 |
| 93 | Rubinstein-taybi syndrome 1 | Enrichment | EP300 | 1.74 |
| 94 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | EP300 | 1.74 |
| 95 | Adrenocortical carcinoma | Enrichment | PRKAR1A | 1.74 |
| 96 | Gastrointestinal stromal tumor | Enrichment | KIT | 1.68 |
| 97 | Gastroesophageal reflux | Enrichment | RPS6KA3 | 1.62 |
| 98 | Orthostatic intolerance | Enrichment | RPS6KA3 | 1.62 |
| 99 | Lennox-gastaut syndrome | Enrichment | MAPK10 | 1.62 |
| 100 | Charge syndrome | Enrichment | EP300 | 1.57 |
| 101 | Ventricular septal defect | Enrichment | RPS6KA3 | 1.57 |
| 102 | Lip and oral cavity carcinoma | Enrichment | KIT | 1.45 |
| 103 | Acute promyelocytic leukemia | Enrichment | PRKAR1A | 1.41 |
| 104 | Polydactyly, postaxial, type a1 | Enrichment | EP300 | 1.35 |
| 105 | Rare genetic intellectual disability | Enrichment | EP300 | 1.35 |
| 106 | Heart, malformation of | Enrichment | MAPK1 | 1.28 |
| 107 | Microcephaly | Enrichment | EP300, MAPK1 | 1.27 |
| 108 | Kallmann syndrome | Enrichment | SOX10 | 1.17 |
| 109 | Ear malformation | Enrichment | MITF | 1.15 |
| 110 | Hirschsprung disease 1 | Enrichment | SOX10 | 1.08 |
| 111 | Non-syndromic x-linked intellectual disability | Enrichment | RPS6KA3 | 0.99 |
| 112 | Non-syndromic genetic deafness | Enrichment | MITF | 0.99 |
| 113 | Leukemia, acute myeloid | Enrichment | KIT | 0.94 |
| 114 | Nonsyndromic hearing loss | Enrichment | MITF | 0.92 |
| 115 | Hypertelorism | Enrichment | RPS6KA3 | 0.84 |
| 116 | Hereditary breast ovarian cancer syndrome | Enrichment | MITF | 0.81 |
| 117 | Primary ciliary dyskinesia | Enrichment | PRKAR1B | 0.69 |
| 118 | Colorectal cancer | Enrichment | EP300 | 0.63 |
| 119 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ADCY1 | 0.63 |
| 120 | Ovarian cancer | Enrichment | KIT | 0.58 |